Currently trading significantly below fair value of $1 based on the current $28m run rate and valuation of peer companies often well above 10x sales during the high growth stages. Less then 2x revenue is simply grossly undervalued for a stock of this quality. The hard numbers (the facts) speak for themselves:
(I try to follow and copy our "friend" with a one liner, but I can't bring myself to make such a mindless and useless post based on nothing but my thoughts - don't know how he does it)![]()
- Forums
- ASX - By Stock
- CMS Proposes Major Increase in Reimbursement for Canaloplasty
Currently trading significantly below fair value of $1 based on...
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
22.0¢ |
Change
0.010(4.76%) |
Mkt cap ! $50.39M |
Open | High | Low | Value | Volume |
21.5¢ | 22.5¢ | 21.0¢ | $84.60K | 389.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 100224 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 23847 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 95224 | 0.220 |
3 | 59542 | 0.215 |
3 | 100000 | 0.210 |
5 | 131536 | 0.205 |
15 | 230879 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 23847 | 1 |
0.240 | 70000 | 2 |
0.245 | 6000 | 1 |
0.250 | 200000 | 3 |
0.255 | 125000 | 2 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |